Skip to main content
SpringerLink
Log in

Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Hyponatraemia is one of the most common tumour-related electrolyte disorders. Several clinical, histological and serum factors have been found to influence prognosis, but, to date, there are no studies focusing on the prognostic role of hyponatraemia in mesothelioma. The aim of this study was to assess the prognostic role of hyponatraemia in malignant pleural mesothelioma.

Methods

We analysed 62 consecutive patients with histologically or cytologically proven advanced malignant pleural mesothelioma undergoing chemotherapy at our institution between January 2003 and September 2013.

Results

All patients received a first-line pemetrexed-based chemotherapy. A second-line chemotherapy was administered to 29 patients.

The onset of hyponatraemia (serum sodium <135 mEq/L) during the treatment was significantly related to a worsened median overall survival (7.93 vs 13.48 months; p = 0.0069). The occurrence of hyponatraemia during first-line chemotherapy (cutoff 135 and 130 mEq/L) was significantly associated to a shorter median progression-free survival (p = 0.0214). Results were also similar in the subgroup receiving a second-line treatment. At the multivariate analysis, including haemoglobin and sodium level at the beginning of first-line chemotherapy, age, gender, smoking habit, job exposure and performance status, only hyponatraemia was found to be an independent factor (p = 0.029). Hyponatraemia was also found to be a predictive factor for both first-line chemotherapy, being related to poorer response to pemetrexed-based chemotherapy (p = 0.047) and second-line chemotherapy (p = 0.044).

Conclusion

Our results show that hyponatraemia might be considered a negative prognostic parameter in malignant pleural mesothelioma patients. To our knowledge, this is the first study to evaluate the association of hyponatraemia with the outcome of malignant pleural mesothelioma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ghali JK (2008) Mechanisms, risks, and new treatment options for hyponatremia. Cardiology 111:147–157

    Article  CAS  PubMed  Google Scholar 

  2. Sengupta A, Banerjee SN, Biswas NM, Jash D, Saha K, Maji A, Bandyopadhyaya A, Agarwal S (2013) The incidence of hyponatraemia and its effect on the ECOG performance status among lung cancer patients. J Clin Diagn 7:1678–1682

    Google Scholar 

  3. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119:71 e1–71 e8

    Article  Google Scholar 

  4. Castillo JJ, Vincent M, Justice E (2012) Diagnosis and management of hyponatremia in cancer patients. Oncologist 17:756–765

    Article  PubMed Central  PubMed  Google Scholar 

  5. Petereit C, Zaba O, Teber I, Lüders H, Grohé C (2013) A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan. BMC Pulm Med 29:13–55

    Google Scholar 

  6. Berghmans T, Paesmans M, Body JJ (1999) A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer 8:192–197

    Article  Google Scholar 

  7. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644

    Article  CAS  PubMed  Google Scholar 

  8. Weder W, Opitz I (2012) Multimodality therapy for malignant pleural mesothelioma. Ann Cardiothorac Surg 1:502–507

    PubMed Central  PubMed  Google Scholar 

  9. Pass HI (2012) Biomarkers and prognostic factors for mesothelioma. Ann Cardiothorac Surg 1:449–456

    PubMed Central  PubMed  Google Scholar 

  10. Jeppesen AN, Jensen HK, Donskov F, Marcussen N, von der Maase H (2010) Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma. Br J Cancer 102:867–872

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK (2012) Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis 59:222–228

    Article  CAS  PubMed  Google Scholar 

  12. Waikar SS, Mount DB, Curhan GC (2009) Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122:857–865

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257–260

    Article  CAS  PubMed  Google Scholar 

  14. Berghmans T (1996) Hyponatremia related to medical anticancer treatment. Support Care Cancer 4:341–350

    Article  CAS  PubMed  Google Scholar 

  15. Bissett D, Cornford EJ, Sokal M (1989) Hyponatraemia following cisplatin chemotherapy. Acta Oncol 28:823

    Article  CAS  PubMed  Google Scholar 

  16. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I, van Heyningen C (2006) Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin Endocrinol (Oxf) 65:246–249

    Article  Google Scholar 

  17. Sørensen JB, Andersen MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97–110

    Article  PubMed  Google Scholar 

  18. Silverman P, Distelhorst CW (1989) Metabolic emergencies in clinical oncology. Semin Oncol 16:504–515

    CAS  PubMed  Google Scholar 

  19. Talmi YP, Hoffman HT, McCabe BF (1992) Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol 101:946–949

    Article  CAS  PubMed  Google Scholar 

  20. Baylis PH (2003) The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 35:1495–1499

    Article  CAS  PubMed  Google Scholar 

  21. Perks WH, Crow JC, Green M (1978) Mesothelioma associated with the syndrome of inappropriate secretion of antidiuretic hormone. Am Rev Respir Dis 117:789–794

    CAS  PubMed  Google Scholar 

  22. Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G (1998) Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16:145–152

    CAS  PubMed  Google Scholar 

  23. Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113:723–731

    Article  CAS  PubMed  Google Scholar 

  24. Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O’Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55:731–735

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Vasudev NS, Brown JE, Brown SR, Rafiq R, Morgan R, Patel PM, O’Donnell D, Harnden P, Rogers M, Cocks K et al (2008) Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res 14:1775–1781

    Article  CAS  PubMed  Google Scholar 

  26. Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, Jang J, Kim HJ, Ko Y, Lim HY, Kang WK (2007) Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 73:192–197

    Article  PubMed  Google Scholar 

  27. Aggerholm-Pedersen N, Rasmussen P, Dybdahl H et al (2011) Serum natrium determines outcome of treatment of advanced GIST with imatinib: a retrospective study of 80 patients from a single institution. ISRN Oncol 2011:523915

    PubMed Central  PubMed  Google Scholar 

  28. Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, Pujol JL (2008) OncoLR Health Network. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 19:1458–1464

    Article  CAS  PubMed  Google Scholar 

  29. Hansen O, Sørensen P, Hansen KH (2010) The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer 68:111–114

    Article  PubMed  Google Scholar 

  30. Petereit C, Zaba O, Teber I, Grohé C (2011) Is hyponatremia a prognostic marker of survival for lung cancer? Pneumologie 65:565–571

    Article  CAS  PubMed  Google Scholar 

  31. Schutz FA, Xie W, Donskov F et al (2014) The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium. Eur Urol 65:723–730

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Conflict of interest

All authors disclose no financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work or that could be perceived as prejudicing the impartiality of the research reported. The authors have full control of all primary data and do agree to allow the journal to review their data if requested.

Author information

Authors and Affiliations

  1. Medical Oncology Unit, Università Politecnica delle Marche – Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I – GM Lancisi – G Salesi, Via Conca 71, 60126, Ancona, Italy

    R. Berardi, M. Caramanti, I. Fiordoliva, F. Morgese, A. Savini, S. Rinaldi, M. Torniai, M. Tiberi, C. Ferrini, M. Castagnani, F. Rovinelli, A. Onofri & S. Cascinu

Authors
  1. R. Berardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Caramanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Fiordoliva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Morgese
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Savini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Torniai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Tiberi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. Ferrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Castagnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F. Rovinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. Onofri
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S. Cascinu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Berardi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berardi, R., Caramanti, M., Fiordoliva, I. et al. Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma. Support Care Cancer 23, 621–626 (2015). https://doi.org/10.1007/s00520-014-2398-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2398-6

Keywords

Search

Navigation